Literature DB >> 19038895

Symptomatic remission in a multiracial urban population of older adults with schizophrenia.

Azziza Bankole1, Carl I Cohen, Ipsit Vahia, Shilpa Diwan, Nikhil Palekar, Pia Reyes, Mamta Sapra, Paul M Ramirez.   

Abstract

OBJECTIVE: Symptomatic remission has been reported in younger patients with schizophrenia. This study aims to determine the prevalence of symptomatic remission in older adults with schizophrenia.
METHODS: The Schizophrenia Group consisted of 198 persons aged 55+ years living in the community who developed schizophrenia before age 45 years. Our definition of remission was adapted from the criteria of the Remission in Schizophrenia Working Group. To attain remission, persons had to have scores of <3 on eight domains of the Positive and Negative Symptom Scale and no hospitalizations within the previous year. Using George's Social Antecedent Model, we examined the association of remission with 18 predictor variables.
RESULTS: Forty-nine percent of the sample met the criteria for symptomatic remission. In logistic regression analysis, four variables--fewer total network contacts, greater proportion of intimates, fewer lifetime traumatic events, and higher Dementia Rating Scale scores--were significantly associated with remission.
CONCLUSIONS: Remission rates were consistent with those reported in younger samples. Our findings suggest that symptomatic remission is an attainable goal and that treatments focused on those variables associated with remission may augment outcomes in older persons with schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 19038895      PMCID: PMC2777609          DOI: 10.1097/JGP.0b013e31818af801

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  33 in total

1.  Brief objective measures for the determination of mental status in the aged.

Authors:  R L KAHN; A I GOLDFARB; M POLLACK; A PECK
Journal:  Am J Psychiatry       Date:  1960-10       Impact factor: 18.112

2.  Socioeconomic status and health across the life course: progress and prospects.

Authors:  Linda K George
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2005-10       Impact factor: 4.077

3.  The stress process.

Authors:  L I Pearlin; M A Lieberman; E G Menaghan; J T Mullan
Journal:  J Health Soc Behav       Date:  1981-12

4.  Toward a resolution of methodological dilemmas in network mapping.

Authors:  J Sokolovsky; C I Cohen
Journal:  Schizophr Bull       Date:  1981       Impact factor: 9.306

5.  Catamnestic long-term study on the course of life and aging of schizophrenics.

Authors:  L Ciompi
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

6.  Neurobiology and the natural history of schizophrenia.

Authors:  Jeffrey A Lieberman
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

7.  Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.

Authors:  Marc De Hert; Ruud van Winkel; Martien Wampers; John Kane; Jim van Os; Joseph Peuskens
Journal:  Schizophr Res       Date:  2007-03-02       Impact factor: 4.939

8.  Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study.

Authors:  Martin Harrow; Linda S Grossman; Thomas H Jobe; Ellen S Herbener
Journal:  Schizophr Bull       Date:  2005-07-14       Impact factor: 9.306

9.  Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Authors:  Diego Novick; Josep Maria Haro; David Suarez; Martin Lambert; Jean-Pierre Lépine; Dieter Naber
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.530

10.  Nondementia nonpraecox dementia praecox? Late-onset schizophrenia.

Authors:  D V Jeste; L L Symonds; M J Harris; J S Paulsen; B W Palmer; R K Heaton
Journal:  Am J Geriatr Psychiatry       Date:  1997       Impact factor: 4.105

View more
  4 in total

1.  Characteristics and Service Use of Older Adults with Schizoaffective Disorder Versus Older Adults with Schizophrenia and Bipolar Disorder.

Authors:  Stephanie A Rolin; Kelly A Aschbrenner; Karen L Whiteman; Emily Scherer; Stephen J Bartels
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-03       Impact factor: 4.105

Review 2.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

Review 3.  Management of schizophrenia in late life with antipsychotic medications: a qualitative review.

Authors:  Takefumi Suzuki; Gary Remington; Hiroyuki Uchida; Tarek K Rajji; Ariel Graff-Guerrero; David C Mamo
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

4.  Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia.

Authors:  Mehmet Hanifi Kokaçya; Osman Virit; Ümit Sertan Çöpoğlu; Haluk Savaş; Mustafa Ari; Bülent Bahçeci
Journal:  Noro Psikiyatr Ars       Date:  2016-12-01       Impact factor: 1.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.